Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS

Giovanni Novi, Federico Ivaldi, Elvira Sbragia, Malgorzata Mikulska, Giampaola Pesce, Maria Matilde Inglese, Nicole Kerlero de Rosbo, Antonio Uccelli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNeurology(R) neuroimmunology & neuroinflammation
Issue number3
Publication statusPublished - May 1 2020

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this